Studies of circadian rhythms have shown how life on Earth resonates to the daily recurring environmental cycles, with profound influences on multiple levels, ranging from behavior to physiology, all of the way to gene expression rhythms in organs and individual cells ([@r1], [@r2]). One of the most intriguing questions in chronobiology is how the transmission of rhythmic signals from the core oscillator to clock output functions is implemented across the many regulatory layers of gene expression ([@r3]).

Significant fractions, up to 20%, of expressed transcripts are found to oscillate with a 24-h period in various organs ([@r4]). In mouse liver, genome-wide profiling of transcription and RNA accumulation over the 24-h day showed that mRNA abundances can oscillate without rhythmic transcription, suggesting posttranscriptional control of a significant fraction of the rhythmic transcriptome ([@r5][@r6][@r7]--[@r8]).

Whether the mRNA degradation rate of a transcript, or equivalently its half-life, is constant or rhythmic predicts quantitatively distinct temporal profiles of mRNA accumulation ([@r9]). Specifically, if an mRNA is rhythmically transcribed but degraded at a constant rate, the peak of mRNA abundance (phase) will be delayed between 0 h and maximally 6 h after synthesis, with a damped oscillation. However, if degradation rate is also rhythmic, then the phase delay can flexibly vary between 0 and 24 h, and the relative amplitudes could be either damped or magnified. Thus, the combined effects of rhythmic synthesis and rhythmic degradation can, in principle, lead to temporal gene expression profiles with diverse amplitudes and phases ([@r9]).

Mechanisms regulating the degradation of transcripts include the recruitment of RNA-binding proteins (RBPs) to the 3′-untranslated region (3′-UTR) of transcripts, as well as targeting of transcripts by miRNAs ([@r10]). Biochemical studies of individual genes have shown that half-lives of mRNAs can fluctuate during the circadian cycle ([@r11]). Notably, studies on mammalian core clock genes, such as *Per1* ([@r12]), *Per2* ([@r13]), *Per3* ([@r14][@r15]--[@r16]), and *Cry1* ([@r17]), found fluctuating mRNA half-lives governed by RNA-binding regulators. mRNA degradation also regulates systemically driven rhythmic transcripts, such as *Tfrc*, *Fus*, and *Cirbp* ([@r7], [@r18]). However, understanding how the respective contributions of transcription and mRNA degradation shape temporal regulation of physiology and gene expression in a complex organ such as the liver remains challenging at a genome-wide scale. While transcription during the diurnal cycle in tissues can be estimated in vivo through Pol II loading on genes ([@r7]), or approximated with nascent RNA ([@r6]) or pre-mRNA ([@r5], [@r8], [@r19]), direct measurements of mRNA degradation rates, which may also vary over the course of the day, poses challenges. Experimental approaches using inhibitors of transcription as well as metabolic pulse labeling of nascent RNA can yield genome-wide insights in mRNA production and degradation in eukaryotic cells ([@r20][@r21][@r22][@r23]--[@r24]). However, these techniques may complicate analyses due to potential biases. For example, antibiotics that block transcription can arrest growth, and metabolic labeling of RNAs can inhibit rRNA synthesis ([@r25], [@r26]). While these methods have been successfully used in plants ([@r27]), they are not currently adapted to measure dynamics of synthesis and degradation of mammalian mRNAs in vivo, such as in the intact liver.

Noninvasive techniques such as dual-color labeling of introns and exons by single-molecular FISH could infer transcription and degradation rates of individual genes in mouse liver, although this approach relied on other quantities that are also challenging to measure, such as transcription elongation rates ([@r28]). Recently, a promising avenue to identify regulatory control points in gene expression is to integrate measurements on multiple omics levels with predictions from kinetic production--degradation models ([@r9], [@r18], [@r22], [@r29], [@r30]).

Here, we extended the approach in ref. [@r9] by developing a model selection framework to systematically identify the contributions of transcriptional and posttranscriptional regulation from times series pre-mRNA and mRNA profiles in mouse liver, without additional external input such as mRNA half-lives. We found that rhythmic transcription with constant mRNA degradation drove a majority of rhythmic mRNAs (∼65%), while rhythmic mRNA degradation with constant or rhythmic transcription regulated ∼35%. Importantly, our method yielded estimates of mRNA half-lives and RNA processing times for thousands of transcripts in mouse liver. We predicted rhythmically active RBPs that regulate rhythmic mRNA degradation. Overall, our analysis revealed that rhythmic mRNA degradation is exploited not only to generate rhythms but also to flexibly fine-tune oscillatory amplitudes and peak timings of mRNA rhythms depending on the mRNA half-life. Finally, we analyzed transcriptomes of liver from *Bmal1*^*−/−*^ mice to show that rhythmic mRNA degradation was often independent of functional BMAL1, but originated most likely from systemic signals driven by feeding--fasting or sleep--wake cycles.

Results {#s1}
=======

A Kinetic Model Identifies Rhythmically Transcribed and Rhythmically Degraded Transcripts from Total RNA-Seq. {#s2}
-------------------------------------------------------------------------------------------------------------

The temporal accumulation of mRNAs in cells is governed by many processes including transcription, (cotranscriptional) splicing, polyadenylation, mRNA export, and mRNA degradation. In the context of 24-h diurnal rhythms, we can assume that mRNA levels are for the most part determined by the kinetics of transcription and mRNA degradation, since the other RNA processing steps occur on faster timescales ([@r28], [@r31][@r32]--[@r33]). Here, we combined a kinetic model for mRNA accumulation with time course measurements of pre-mRNA and mRNA ([Fig. 1*A*](#fig01){ref-type="fig"}) simultaneously quantified from the same biological samples, using recently published RNA-seq data from 48 total RNA time points collected along a daily cycle with 2-h resolution in mouse liver ([@r8]) ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental) and [Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)).

![Kinetic model identifies contributions and parameters of rhythmic transcription and rhythmic degradation regulating mRNAs from total RNA-seq. (*A*) Temporal accumulations of mRNA and pre-mRNA from time-resolved total RNA-seq were used to fit four kinetic models (M1--M4). The rate equation for the temporal accumulation of mRNA $m\left( t \right)$ depends on pre-mRNA $p\left( t \right)$ and the degradation rate $\gamma\left( t \right)$, which are either constant or parameterized with periodic functions ([*Materials and Methods*](#s9){ref-type="sec"}). The models allow for constant (C) or rhythmic (R) synthesis (S) and degradation (D) in the four combinations: M1 (constant synthesis and constant degradation, CS-CD), M2 (rhythmic synthesis and constant degradation, RS-CD), M3 (constant synthesis and rhythmic degradation, CS-RD), and M4 (rhythmic synthesis and rhythmic degradation, RS-RD). Probabilities for each model are estimated using Schwarz weights ([*Materials and Methods*](#s9){ref-type="sec"}); the optimal model for each mRNA (one per gene; [*Materials and Methods*](#s9){ref-type="sec"}) also yields gene-specific parameters (e.g., mRNA half-life, processing time, phases, and amplitudes of rhythmic degradation rates). We applied this approach genome-wide. (*B*--*D*) Temporal profiles of mRNA and pre-mRNA of genes assigned to models M2--M4. Data for mRNA (blue) and pre-mRNA (green) with error bars (SE over four biological replicates) are shown as relative expression, that is, the total normalized counts divided by the average value over time. Solid curves are the fitting for the optimal model and estimated parameters (blue, mRNA; green, pre-mRNA; red, degradation). Peak times (phase) and amplitudes are summarized in circle plots. The radial scale of these plots is relative to the largest relative amplitude of mRNA, pre-mRNA, or rhythmic degradation. Absolute half-lives \[${\log\left( 2 \right)}/\gamma_{0}$, in hours\], if identifiable, are labeled. (*B*) M2: (*Left*) *Cp* had long estimated hl (7.9 h), which damped amplitude of mRNA compared with that of pre-mRNA; (*Right*) *Rorc* mRNA was identified in M2 (RS-CD) with estimated constant hl of 2.1 h. (*C*) M3: *Fus* mRNA was identified in M3 (CS-RD). The peak time of rhythmic degradation (RD) was ZT18.3 and the relative amplitude of RD was 0.3. Mean half-life was nonidentifiable ([*Materials and Methods*](#s9){ref-type="sec"}). (*D*) M4: (*Left*) *Per3* mRNA was identified in M4 (RS-RD). The RD showed a maximum at ∼ZT18, and a relative amplitude of 0.5 mean degradation rate was identifiable with mean hl of 1.6 h; (*Right*) *Cbs* mRNA showed a phase delay between mRNA and pre-mRNA \> 6 h, which could be explained by M4. Parameters of RD showed a maximum at ∼ZT9 with a mean hl of 8.6 h.](pnas.1715225115fig01){#fig01}

To confidently use those RNA-seq data to distinguish between rhythmic transcript synthesis and degradation, we first confirmed that temporal profiles for the pre-mRNAs of circadian clock genes, estimated using intronic reads ([*Materials and Methods*](#s9){ref-type="sec"}), corroborated with those estimated from nascent RNA sequencing ([Fig. S1*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) ([@r6]). Indeed, because pre-mRNAs are short lived and rapidly processed within seconds to minutes ([@r22], [@r23], [@r29], [@r34]), their profiles estimated from total RNA-seq have been shown to provide good proxies for transcription ([@r5], [@r19], [@r30], [@r35]). Genome-wide, the peak times (also referred to as phases) of pre-mRNA accumulation for cycling genes identified from total and nascent RNA-seq data were highly correlated ([Fig. S1*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). As expected from previous works on daily rhythmic transcription ([@r5][@r6]--[@r7], [@r36]), pre-mRNAs showed a biphasic enrichment near ZT8 (ZT, zeitgeber time) and ZT20 ([Fig. S1 *C* and *D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), consistent with the day and night transcriptional waves in the liver. Moreover, pre-mRNA levels preceded the accumulation of the corresponding mRNAs by 1.7 h on average ([Fig. S1*E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). Assuming constant mRNA degradation, the relative amplitudes of pre-mRNAs would be higher than those of mRNAs, which is observed on average ([Fig. S1*E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). However, the observed subset of transcripts with higher peak-to-trough amplitudes in the mRNA likely indicates posttranscriptional regulation, as analyzed below. In the following, we often use the term amplitude for peak-to-trough amplitude, as it is clear from the context what is meant.

Next, we developed a computational method to analyze rhythmic transcription and degradation, which uses absolute pre-mRNA and mRNA levels as inputs to distinguish, on a gene-by-gene basis, between four kinetic models (M1--M4) ([Fig. 1*A*](#fig01){ref-type="fig"}). These four models assume the following: constant RNA synthesis (CS) and constant degradation (CS-CD, also termed M1), or rhythmic synthesis (RS) and constant degradation (RS-CD or M2), constant synthesis and rhythmic degradation (CS-RD or M3), and rhythmic synthesis with rhythmic degradation (RS-RD or M4). By combining a maximum-likelihood approach with the Bayesian information criterion (BIC), we then select an optimal model. We first validated this model selection and parameter estimation by simulating data for all four models using realistic parameters, including noise levels ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). We found that the classification accuracy was nearly perfect for M1 and M2 ([Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). For M3, the performance depended on the amplitude of the simulated mRNA, but was near perfect for mRNA amplitudes above 1.1-fold ([Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). For M4, the classification properly identified rhythmic degradation when this changed the amplitude and peak time of mRNA levels beyond what is obtained from pure rhythmic synthesis ([Fig. S2 *A*--*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). These simulations also allowed us to determine when the kinetic parameters are reliably identifiable, and the regimes in which some parameters are structurally or practically not identifiable ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). In general, the estimated model parameters followed those in the simulations ([Fig. S2*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), including mRNA processing time and half-life, except for M3. Indeed, in M3, while the ratio of half-life to processing time is well estimated, we found that the mean half-life alone is often practically nonidentifiable ([@r37]) ([Fig. S2 *D*--*F*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). In this situation, we nevertheless obtain a lower bound on the relative amplitude of rhythmic mRNA degradation, which is biologically relevant. Moreover, the peak time of rhythmic degradation, whose precise estimation depends on the half-life, can still be placed within a 6-h window, from being antiphasic to that of mRNA accumulation, to peaking 6 h after peak mRNA accumulation. To assess whether half-life could be reliably identified, we implemented the profiling likelihood (PL) method ([@r37]) ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental), [Fig. S2*F*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental), and [Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). We thus conclude that that despite the identifiability issue for kinetic parameters in M3, the model selection was overall able to detect even small temporal changes in rhythmic degradation ([Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)).

Given these validations, we then applied our model to the total RNA-seq measurements and retrieved the optimal model as well as the estimated parameters of 12,216 expressed genes in liver ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental) and [Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). To appreciate the diversity of the temporal profiles and their regulations, we first show representative examples from each model ([Fig. 1 *B*--*D*](#fig01){ref-type="fig"} and [Fig. S3 *A*--*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). As expected, genes assigned to M2 (constant degradation, RS-CD) showed damped amplitudes and phase delays in temporal mRNA accumulation compared with pre-mRNA. For example, *Rorc* showed mRNA accumulation with a short delay and slightly damped amplitude compared with pre-mRNA ([Fig. 1*B*](#fig01){ref-type="fig"}); its mRNA half-life (hl) was estimated to be 2.1 h. Meanwhile, long-lived genes such as *Cp* (estimated hl, 7.9 h) had long phase delays (∼6 h) and significantly damped oscillations (more examples for M2 in [Fig. S3*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). Our approach also identified rhythmic mRNAs regulated by rhythmic degradation and constant synthesis (CS-RD, M3), such as *Fus* ([Fig. 1*C*](#fig01){ref-type="fig"}). This observation is consistent with previous studies showing that *Fus* had constitutive RNA polymerase II (Pol II) loading and its mRNA rhythm was generated posttranscriptionally ([@r7]). Although the absolute value of the mRNA degradation rate for *Fus* was unidentifiable, we could estimate a peak-to-trough amplitude of at least 1.8-fold. Finally, we found that rhythmic synthesis and degradation (RS-RD, M4) can simultaneously regulate mRNA rhythms, resulting in amplified amplitudes or long phase delays ([Fig. 1*D*](#fig01){ref-type="fig"} and [Fig. S3*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). For instance, *Per3* mRNA stability was previously reported as time dependent, besides being transcriptionally regulated by BMAL1:CLOCK ([@r14], [@r16], [@r36]). Here, we observed that *Per3* mRNA accumulation oscillated with relative amplitude comparable, or only slightly higher, than the pre-mRNA with a delay that was short given the estimated hl of 1.6 h ([Fig. 1*D*](#fig01){ref-type="fig"}, gray line). This short delay was accomplished by rhythmic mRNA degradation, which varied by approximately threefold during the day, with the peak at ZT18 (hl, 1 h) and the trough at ZT6 (hl, 3 h). Without rhythmic degradation, *Per3* would either show dampened oscillations or lower average accumulation levels. Time of peak mRNA accumulation of *Cbs*, another M4 gene, occurred more than 6 h later than that of its pre-mRNA. This long delay follows from the combined rhythmic synthesis and degradation. These examples illustrate that rhythmic degradation can influence mRNA accumulation profiles in diverse manners, depending on the relationships of means values, phases, and amplitudes of mRNA synthesis and degradation, as detailed mathematically in ref. [@r9].

Together, these results demonstrate that our model can reliably distinguish among different regulatory scenarios leading to rhythmically accumulating mRNAs, in particular ones involving rhythmic mRNA degradation. Despite some limitations for constantly transcribed genes, we could also estimate gene-specific parameters such as mRNA half-lives.

Rhythmic Degradation Regulates 35% of Rhythmically Accumulating Transcripts. {#s3}
----------------------------------------------------------------------------

We then focused on the predicted classes for all rhythmically accumulating mRNAs \[6,014 mRNA profiles selected through harmonic regression, false discovery rate (FDR) \< 5%\] and assessed whether they fell into M2, driven by rhythmic transcription alone; M3, driven by rhythmic degradation alone; or M4, driven by both rhythmic transcription and degradation.

Rhythmic transcription with constant degradation (M2) regulated 3,949 (∼65%) mRNAs ([Fig. 2*A*](#fig02){ref-type="fig"}), consistent with previously reported results ([@r7], [@r9]). Constant transcription with rhythmic degradation (M3) regulated 1,167 mRNAs (∼20%). Genes in M3 were enriched for translation regulation, RNA transport, and mRNA catabolic processes ([Dataset S2](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). Last, rhythmic transcription and degradation combined (M4) controlled 898 mRNAs (15%), whose functions were enriched for lipid and steroid biosynthetic processes, and circadian regulation ([Dataset S2](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)).

![Rhythmic mRNA degradation regulates 35% of rhythmically accumulating mRNAs (∼20% in M3 and 15% in M4). (*A*) Numbers and percentages of rhythmic mRNAs (6,014 with FDR \< 0.05, harmonic regression) identified in M2 (3,949), M3 (1,167), and M4 (898). (*B*, *Left*) Percentages of mRNAs subjected to RD estimated using the PA test, which were assigned to either M3 or M4 by our method. The analysis is stratified in function of the stringency of the PA test (log~10~ *P* values). We used published measurements of half-lives from cell lines as input for the PA test. (*Right*) Distribution of *P* values from the PA test according to the classification from our method. (*C* and *D*) Distributions of peak times (*C*) and amplitudes (*D*) of rhythmic mRNAs in M2--M4.](pnas.1715225115fig02){#fig02}

To assess these results using an independent approach, we applied the production--abundance test (PA test) to identify transcripts subjected to posttranscriptional regulation ([@r9]) ([Dataset S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). The PA test is based on the null hypothesis of constant degradation rather than the data-driven model selection developed here, and is thus limited to the rejection of models M1/M2. The PA test requires proxies for transcription (Pol II ChIP, nascent RNAs, or pre-mRNAs), mRNA accumulation, and experimentally measured mRNA half-lives \[e.g., from mouse fibroblast cell lines ([@r21], [@r38])\]. Transcripts identified as incompatible with M1/M2 by the PA test were clearly enriched in genes classified as M3 and M4 ([Fig. 2*B*](#fig02){ref-type="fig"}). Conversely, genes assigned to M3 and M4 by our method displayed overall lower significant scores by the PA test compared with M1 and M2 genes ([Fig. 2*B*](#fig02){ref-type="fig"}).

We then investigated the phases and amplitudes of M2--M4 genes. We observed that, although the mechanisms generating the rhythms differed, peak times of rhythmic mRNAs were similar across the three groups ([Fig. 2*C*](#fig02){ref-type="fig"}). However, even though genes in M4 were more abundantly expressed compared with those in M2 or M3 ([Fig. S3*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), indicating that they might have longer half-lives, the peak-to-trough amplitudes of oscillating mRNAs in M4 were larger than ones in M2 or M3 ([Fig. 2*D*](#fig02){ref-type="fig"}; see also further discussion below). Interestingly, we found that mRNAs in M2, M3, and M4 more often showed a rhythmic poly(A) tail length compared with M1 ([Fig. S3*E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), potentially due to the influence of poly(A) tail length on mRNA stability ([@r39]) and possibly reflecting the proposed coupling between rhythmic transcription and polyadenylation ([@r39]).

Estimated mRNA Half-Lives and RNA Processing Times in Mouse Liver. {#s4}
------------------------------------------------------------------

In addition to disentangling transcriptional and posttranscriptional contributions governing temporal mRNA profiles, our models estimated peak time and amplitude of rhythmic degradation as well as parameters that are otherwise difficult to estimate in vivo, notably mRNA degradation rate and pre-mRNA processing time ([Fig. 3 *A* and *B*](#fig03){ref-type="fig"}, [Fig. S4*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental), and [Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). mRNA half-lives in M2 and M4 (half-lives of M3 are not shown due to poor identifiability; see above) were overall short compared with the 24-h day, with a median of ∼2.5 h, consistent with the observation that most of mRNAs continued to oscillate ([@r3]). M4 was enriched in long half-lives compared with M2, with a long-tailed distribution ranging up to 20 h ([Fig. 3*A*](#fig03){ref-type="fig"}).

![Distributions of estimated half-lives and processing times of mRNA in mouse liver. (*A*) Distribution of estimated mRNA half-lives \[${\log\left( 2 \right)}/\gamma_{0}$, in hours\] in M2 and M4 for transcripts with identifiable half-lives. Vertical lines indicate the medians of the distributions. (*B*) Distribution of pre-mRNA processing times ($1/k$, in minutes) in models M2 and M4. Vertical lines indicate the medians of the distributions for transcripts with identifiable parameters. (*C*) Half-lives and processing times of core clock and clock output mRNAs. We plotted standard errors (SEs) of the estimates when available ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental) and [Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)).](pnas.1715225115fig03){#fig03}

mRNA half-lives of several core clock and clock output genes, for example, *Clock*, *Per1/3*, *Nr1d1/2*, and *Dbp*, were estimated between 1 and 2 h, which is in the range of estimates in cell culture ([@r40]) ([Fig. 3*C*](#fig03){ref-type="fig"}). Although the estimated half-lives in the liver correlated with measurements in NIH 3T3 cells ([@r38]) ([Fig. S4*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), the significant spread probably reflects cell type-specific degradation kinetics, in addition to technical variability. Of note, comparison of measured half-lives in NIH 3T3 and mouse embryonic stem cells ([@r41]) shows a similar dispersion ([Fig. S4*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). Since the PA test is sensitive to the half-lives used as input, the partial overlap between the two methods might reflect cell type-specific half-lives ([Fig. 2*B*](#fig02){ref-type="fig"}). Overall, half-lives estimated in mouse liver were shorter compared with those in cell lines. Likewise, the effective pre-mRNA processing times could be estimated for M2 and M4 ([Fig. 3*B*](#fig03){ref-type="fig"}). The found values in the range of 5--10 min are similar with earlier estimates in cell culture models ([@r22], [@r23], [@r29], [@r42]). Median processing times of mRNAs in both M2 and M4 were found around 7 min. Overall, we estimated half-lives and processing times for over 3,000 mRNA transcripts in mouse liver ([Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), including those of core clock and clock output genes ([Fig. 3*C*](#fig03){ref-type="fig"}). At the genome-wide level, we observe a correlation between processing times and mRNA half-lives ([Fig. S4*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), which has been previously observed in mouse dendritic cells ([@r22]).

Phases and Amplitudes of Rhythmic mRNA Degradation. {#s5}
---------------------------------------------------

Considering only well-identified mRNA degradations for M3 and M4 ([*Materials and Methods*](#s9){ref-type="sec"}), we found that the estimated phases and amplitudes ([Fig. 4](#fig04){ref-type="fig"}) were consistent with those from the PA test ([Fig. S4*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). Peak times of RD in M3 were distributed throughout the day ([Fig. 4*A*](#fig04){ref-type="fig"} and [Fig. S4*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) but depleted around the day--night transition at ZT12. By contrast, peak times of mRNA degradation in M4 showed a marked peak at ZT12. Intriguingly, genes within this peak (between ZT10 and ZT16) encoded for proteins related to the endoplasmic reticulum and vesicle transport to the Golgi, such as *Insig1*, *Sec13*, *Sec22b*, and *Sec23b* ([@r43], [@r44]) ([Dataset S4*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). The amplitudes of mRNA degradation for M3 and M4 showed similar distributions ([Fig. 4](#fig04){ref-type="fig"} and [Fig. S4*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) ranging up to 16-fold, with (∼30%) showing amplitudes greater than 2-fold. Several of those transcripts with high degradation fold changes (log~2~ FC \> 2.5) were linked with RNA splicing \[gene ontology (GO) term analysis, *P* = 9e-4\].

![Phases and amplitudes of rhythmic mRNA degradation. (*A* and *B*) Distribution of estimated phases and peak-to-trough amplitudes (in log~2~) of rhythmic degradation in M3 (*A*) and M4 (*B*) for transcripts with identifiable and high-confidence degradation parameters (coefficient of variation of estimated relative amplitude \<0.4 and SE of estimated phase \<1 h; [*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental) and [Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)).](pnas.1715225115fig04){#fig04}

Rhythmic mRNA Degradation Serves as an Amplifier for Long-Lived mRNAs and Phase Tuner for Short-Lived mRNAs. {#s6}
------------------------------------------------------------------------------------------------------------

Why would a cell use rhythmic degradation when it can generate rhythms transcriptionally? To address this question, we first analyzed the phase relationship between RS and RD for genes with identifiable and high-confidence estimated phase and amplitude ([*Materials and Methods*](#s9){ref-type="sec"}) in M4. If the role of RD were to amplify amplitudes from transcription regulation, we would expect an optimal delay of 12 h between the peak times of RD and RS ([@r9]). Surprisingly, the distribution of delays between RD and RS was broad, showing two modes near 6 and 20 h ([Fig. 5*A*](#fig05){ref-type="fig"}), suggesting that RD plays a role beyond boosting amplitudes. Moreover, we found that genes with delays near 12 h had longer mRNA half-lives ([Fig. 5*A*](#fig05){ref-type="fig"}) and showed ratios of amplitudes in degradation vs. synthesis rates that increased with half-life ([Fig. 5*B*](#fig05){ref-type="fig"}). Meanwhile, genes with 6- and 20-h delays showed comparable relative amplitudes for RD and RS.

![Rhythmic mRNA degradation serves as an amplifier for long-lived mRNAs and phase tuner for short-lived mRNAs. (*A*, *Left*) Histogram of phase delays in M4 (peak time of RD minus peak time of RS). (*Right*) Phase delay vs. mRNA half-lives suggests three classes of transcripts. C1, Long-lived mRNAs (hl \> 5 h; green); C2, short-lived mRNAs with short delay (hl \< 5 h, delay \< 12 h; orange); and C3, short-lived mRNAs with long delay (hl \< 5 h, delay \> 12 h; dark red). (*B*, *Left*) Histogram of relative amplitude ratio $\left( {\varepsilon_{\gamma}/\varepsilon_{s}} \right)$ between RD and RS. (*Right*) Scatterplot of relative amplitude ratio vs. mRNA half-life color-coded for C1--C3. (*C*) Scatterplot of relative amplitudes \[(maximal expression − minimal expression)/2 × (mean of expression)\] of mRNAs in C1 vs. predicted under assumption of constant degradation (*Left*) and vs. relative amplitudes of pre-mRNAs (*Right*) in log scale. (*D*) Scatterplot of peak times of mRNAs in C1 vs. predicted peak times under assumption of constant degradation (*Left*) and vs. peak times of pre-mRNAs (*Right*). (*E*, *Left*) Temporal profiles of pre-mRNA (green) and mRNA (blue) of C1 gene *Smagp* (values are normalized read counts divided by the temporal average; error bars show SE over four biological replicates). The gray line shows predicted mRNA profile under assumption of constant degradation (relative amplitude of mRNA degradation $\varepsilon_{\gamma}$ set to zero). (*Right*) Arrows in the circle plot depict the phase (angular coordinate) and relative amplitude (radial coordinate) of pre-mRNA (green), mRNA (blue), and predicted mRNA under the assumption of constant degradation. (*F*--*H*) Idem as *C*--*E* for genes in C2. Rhythmic degradation advances peak times of mRNAs in C2 without affecting relative amplitude. Pre-mRNA and mRNA of *Wee1* oscillates with comparable phases, whereas assuming constant degradation, its mRNA would show larger phase delays. (*I*--*K*) Idem for genes in C3. Rhythmic degradation delays peak times of mRNAs in C3 without affecting relative amplitude. Pre-mRNA and mRNA of *Slc4a4* show large delays, whereas assuming constant degradation, its mRNA would show smaller phase delays (*K*). (*A*--*K*) Transcripts were selected as for [Fig. 4](#fig04){ref-type="fig"}, with, in addition, a threshold on the rhythmicity of their pre-mRNA and mRNA to ensure reliable phase estimation (FDR \< 0.05 rhythmicity test, and relative amplitude \>0.1; [*Materials and Methods*](#s9){ref-type="sec"}).](pnas.1715225115fig05){#fig05}

To simplify the discussion, we defined three classes (C1--C3) of mRNAs (see colors in [Fig. 5*A*](#fig05){ref-type="fig"}). C1 had long-lived mRNAs (hl \> 5 h); C2 short-lived mRNAs with short delay between RD and RS (hl \< 5 h, delay \< 12 h); and C3 had short-lived mRNAs with long delay (hl \< 5 h, delay \> 12 h). For C1, the 12-h delayed RD (relative to the peak synthesis) increased amplitudes of mRNA oscillations, which were even higher than those of the pre-mRNAs ([Fig. 5*C*](#fig05){ref-type="fig"}). Indeed, if mRNA degradation for those genes were set constant in simulations, mRNA oscillations were strongly dampened ([Fig. 5*C*](#fig05){ref-type="fig"}). Meanwhile, the peaks times of these mRNAs were not much affected by RD due to the 12-h phase delay between RD and RS ([Fig. 5*D*](#fig05){ref-type="fig"}). For illustration, rhythmic degradation amplified mRNA amplitudes of *Smagp* and *Acat3* mRNA without affecting the phases ([Fig. 5*E*](#fig05){ref-type="fig"} and [Fig. S5*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). Thus, for C1 mRNAs, a possible role of RD is to compensate the damping caused by the mRNA half-life while maintaining the phase.

In contrast to mRNAs in C1, the amplitudes of short-lived mRNAs in C2 and C3 were not much influenced by RD ([Fig. 5 *F* and *I*](#fig05){ref-type="fig"}). However, we found that the peak times of mRNAs were either advanced (C2) or delayed (C3) ([Fig. 5 *G* and *J*](#fig05){ref-type="fig"}) relative to simulated constant degradation. Rhythmic degradation of mRNAs in C2 advanced peak times of mRNAs by an average of 1.8 h ([Fig. 5*G*](#fig05){ref-type="fig"}), and thus mRNAs in C2 oscillated almost synchronously with the pre-mRNAs ([Fig. 5*G*](#fig05){ref-type="fig"}), and with comparable amplitudes ([Fig. 5*F*](#fig05){ref-type="fig"}). Many core clock and clock-controlled genes were found in C2 ([Fig. 5*H*](#fig05){ref-type="fig"} and [Fig. S5*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), illustrating the role of RD in advancing phases. Such genes included *Wee1* kinase ([Fig. 5*H*](#fig05){ref-type="fig"}), an inhibitor of CDK1 during the cell cycle, reported as controlled by the circadian clock ([@r45]). Finally, we found that RD delayed peak times for mRNAs in C3 by an average of 2.7 h ([Fig. 5*J*](#fig05){ref-type="fig"}), while maintaining amplitudes ([Fig. 5*I*](#fig05){ref-type="fig"}). We note that some mRNA peak times were delayed beyond 6 h (the maximal allowed with only rhythmic transcription) compared with that of pre-mRNA ([Fig. 5*K*](#fig05){ref-type="fig"} and [Fig. S5*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). For example, rhythmic degradation enabled *Slc4a4* mRNA to peak at ZT6, 6.5 h later than the pre-mRNA ([Fig. 5*K*](#fig05){ref-type="fig"}), while assuming constant degradation we would have expected only a 2-h delay.

Our results thus suggest that rhythmic degradation of short-lived mRNAs tends to fine-tune phases, allowing mRNAs to either oscillate nearly in sync with pre-mRNAs, or delay peak times to beyond theoretical limits under constant degradation assumptions. On the other hand, rhythmic degradation in the case of longer-lived mRNAs primarily increased amplitudes.

BMAL1 Dependence of Rhythmic mRNA Degradation in Liver. {#s7}
-------------------------------------------------------

We next investigated the roles of the circadian clock and of rhythmic systemic cues in the temporal regulation of rhythmic mRNA degradation. For this, we compared the RNA-seq profiles from the WT ad libitum (AL) fed mice used so far with profiles from WT and *Bmal1*^−/−^ mice under night-restricted feeding (RF) (food available only from ZT12 to ZT24, the period of activity for mice) ([@r8]). We focused on the genes classified in M3 under AL feeding, whose rhythmic mRNA expression is solely driven by rhythmic degradation ([Dataset S5](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)). First, the majority (79%, *n* = 920) of these mRNAs continued to oscillate under RF with the same rhythmic parameters as under AL feeding ([Fig. 6*A*](#fig06){ref-type="fig"}, three top groups; see [*Materials and Methods*](#s9){ref-type="sec"} for the selection of the groups), which is not surprising since such night RF only slightly perturbs the feeding rhythm ([@r46]). Second, loss of BMAL1 did not affect the rhythmic expression of 569 out of the 920 mRNAs (62%, top group in [Fig. 6*A*](#fig06){ref-type="fig"}), suggesting that a majority of rhythmic mRNA degradation does not depend on BMAL1, but may instead be regulated by systemic signals originating from feeding rhythms, light--dark, temperature, or sleep--wake cycles. Of the remaining 351 rhythmic mRNAs that were altered in *Bmal1*^*−/−*^ (38%, second and third groups in [Fig. 6*A*](#fig06){ref-type="fig"}), 292 (32%, third group) became arrhythmic and 59 (6%, second group) remained rhythmic with shifted phases or altered amplitudes, indicating that their regulation depends on both BMAL1 and systemic cues.

![BMAL1-dependent and -independent rhythmic mRNA degradation. (*A*) Heat map of mRNA relative expression of genes classified in M3 in mouse liver in the following conditions (biological replicates are averaged): WT ad libitum (AL WT, *Right*; this condition was used for the main analysis, 12 times points, 48 samples), WT restricted feeding (RF WT, *Middle*; 6 time points, 12 samples), and *Bmal1*^*−/−*^ restricted feeding (RF *Bmal1*^*−/−*^; 6 time points, 12 samples). All data are from ref. [@r8] and provided in [Dataset S5](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental), together with the parameter estimates. Genes above the thickest horizontal separator have similar rhythmic parameters in AL WT and RF WT. The two thinner horizontal separators split the genes into those that keep the same rhythmic parameters in RF *Bmal1*^*−/−*^ (*Top*, 569 mRNAs, group 1), those that are expressed in a constant manner (*Bottom*, 292 mRNAs, group 2), and those that exhibit 24-h oscillations with altered rhythmic parameters (*Middle*, 59 mRNAs). (*B*) mRNA peak time distributions for groups 1 and 2. (*C*) Phases of inferred activities of mRBP motifs in groups 1 (blue) and 2 (red). Activities are inferred using a penalized linear model that integrates mRBP binding site at the 3′-UTR of mRNA with phase and amplitude of mRNA degradation ([*Materials and Methods*](#s9){ref-type="sec"}). Angles on the circle indicate peak activity times (ZT times). (*D*) Inferred activities and protein abundance of candidate mRBPs over time ([@r50]). mRBPs are predicted to regulate stability of transcripts from group 1 (plotted in blue), from group 2 (in red), or in some cases from both groups (in purple). Rhythmic activities that are antiphasic to rhythmic protein accumulation predict a stabilizing effect.](pnas.1715225115fig06){#fig06}

Interestingly, BMAL1-dependent and -independent mRNAs showed distinct phase distributions ([Fig. 6*B*](#fig06){ref-type="fig"}): mRNAs whose rhythmic degradation was BMAL1-independent (and thus driven by feeding rhythms or systemic signals) were enriched in the late morning (ZT6--ZT8), while those with BMAL1-dependent degradation enriched in the late night (ZT23). GO term analysis on these two groups ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental) and [Dataset S4 *B*--*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) showed that the BMAL1-dependent group was enriched in regulators of actin filament polymerization or the positive regulation of WNT signaling, while genes whose degradation was driven by rhythms in feeding or systemic signals were enriched in mRNA processing and transport pathways. Interestingly, this latter category contained genes related to poly(A) tail regulation and degradation (*Pan2*, *Parn*, *Pabpc1*, and *Magohb*) or involved in the promotion of nonsense mediated mRNA decay (*Smg7*, *Upf3b*, *Ncbp2*, and *Etf1*).

Finally, we sought to identify putative regulators underlying rhythmic mRNA degradation in each group. We focused here on mRNA binding proteins (mRBPs) since mRNA rhythms were shown to be only weakly affected by perturbation of miRNA biogenesis in mouse liver ([@r19]). Briefly, we first used known mRBP target recognition specificities (binding motifs) ([@r47]) to scan the 3′-UTR regions of each mRNA. Next, we modeled the rhythmic degradation rates for each transcript as a linear combination of unknown mRBP activities associated with each mRBP binding motif ([*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental) and [Dataset S6](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) ([@r35], [@r48], [@r49]). This method allowed us to predict the phase and amplitude of mRBP activities that optimally explained the rhythmic degradation rates of genes in the two main groups ([Fig. 6*C*](#fig06){ref-type="fig"}). In support of these predicted degradation activities, candidate mRBPs showed rhythmic accumulations in proteins from total liver extracts ([@r50]). Interestingly, mRBPs such as MATR3, NCL, FXR1, and NCL, oscillated in opposite phase of predicted degradation activity, corroborating with previous studies that these mRBPs can stabilize mRNAs ([@r51][@r52]--[@r53]) ([Fig. 6*D*](#fig06){ref-type="fig"}). Biochemical studies of SYNCRIP (HNRNP Q) have reported to increase ([@r54]) as well as decrease mRNA stability ([@r15]), depending on the specific mRNA studied.

Taken together, our analyses suggest that mRNA accumulation in the liver is influenced by both clock-dependent and -independent control of mRNA stability, likely through the action of specific mRBP activities.

Discussion {#s8}
==========

We developed a computational method to model temporal total RNA-seq profiles, which can distinguish contributions of transcription and mRNA degradation toward rhythmic mRNA accumulation. Applied to liver transcriptome, we found that about 35% of rhythmic mRNAs are regulated at the posttranscriptional level, most likely through rhythmic mRNA degradation. Such posttranscriptional rhythms could amplify the amplitudes or tune the phases of mRNA oscillations, enabling precise temporal control of mRNA levels. For example, we found that the phase of mRNA of clock genes, such as *Per1* and *Per3*, and clock output genes, such as *Wee1* and *Tef*, are tuned to match that of pre-mRNA accumulation, allowing phase to be encoded transcriptionally. In addition, this method allowed us to infer mRNA half-lives and processing times of over 3,000 transcripts in the intact and unperturbed mouse liver.

The kinetic models analyzed here provide more robust answers regarding the role of posttranscriptional regulation than simpler comparisons between oscillating pre-mRNA and mRNA. Indeed, even if pre-mRNA and mRNA are both rhythmic, rhythmic posttranscriptional regulations can still be involved. To overcome these caveats, our kinetic model takes into account relationships of peak times, amplitudes, and read counts of pre-mRNA and mRNA accumulations. Importantly, in contrast to previous methods ([@r9]), ours does not require experimentally measured mRNA half-lives as input, which are usually measured in cell culture experiments, but rather leverages the temporal RNA-seq profiles to estimate mRNA half-lives in intact organs over time of day.

Although our method might underestimate the contribution of weakly rhythmic degradation, especially for transcripts with rhythmic pre-mRNA and mRNA levels ([Fig. S2](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)), our estimated 35% of rhythmic mRNAs subjected to circadian mRNA degradation is consistent with previous explicit kinetic models ([@r7], [@r9]). Other studies have found that a larger fraction of rhythmic mRNA (78%) could be regulated by rhythmic degradation ([@r5]), which may be partially due to low and noisy intron levels interpreted as constant synthesis.

Clearly, our mathematical model relies on a several assumptions regarding the kinetics of posttranscriptional processes. In particular, we assume that processes such as splicing, polyadenylation, or nuclear export occur on a faster timescale compared with mRNA degradation. In some cases, these assumptions might not hold. For instance, *Cirbp* was reported to be regulated on the level of both its splicing efficiency and mRNA degradation ([@r18]). Nevertheless, *Cirbp* was correctly classified as subject to posttranscriptional regulation. For simplicity, we have interpreted our results assuming that the profiles of pre-mRNA reflected the transcription rates. Although this might not always be the case, such as for *Cirbp*, where the oscillatory pre-mRNA originates from rhythmic splicing efficiency rather than transcription, the genome-wide similarity of nascent RNA and pre-mRNA profiles ([Fig. S1 *A* and *B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) suggest that rhythmic transcription is the most frequent scenario. Moreover, the distribution of estimated mRNA half-lives and RNA processing times are in the range of previously measured values, indicating that our simple model captures the main dynamics regulating mRNA abundances. Regarding mRNA degradation, we have not considered the interesting possibility that mRNA aging, for example, through the shortening of poly(A) tails, might require more complicated modeling. Since a group of transcripts has been shown to exhibit deadenylation rhythms ([@r39]), a future extension of the model might explicitly consider mRNAs of different ages, and possibly infer aging parameters from measurements of poly(A) tail length distributions. In the current description, an effective rhythmic degradation rate could also reflect a rhythmic shift in the average poly(A) tail length, coupled with length-depended mRNA lifetimes.

In this study, we also investigated potential causes of rhythmic mRNA degradation. mRNA half-lives are determined by structural elements such as the length of their poly(A) tail and secondary structure influencing the accessibility and binding of specific mRBPs or miRNAs ([@r10]). While in mouse liver miRNAs have been previously shown to only marginally drive rhythmic accumulation, the potential role of rhythmic actives mRBPs has not been identified genome-wide. Moreover, the respective roles of the circadian clock or other rhythmic cues such as feeding/fasting cycles were not known. Here, our analysis not only predicted several mRBPs underlying rhythms in mRNA degradation, but we could also distinguish between regulators with clock-dependent as well as clock-independent activities, showing approximately equal regulatory proportions. Temporal protein accumulation profiles for the predicted mRBPs supported some of the identified candidates and, interestingly, distinguished between stabilizing and destabilizing effects on mature mRNAs.

We thus found that systemic signals as well as the local clock can drive rhythmic mRNA degradation. Future studies integrating posttranscriptional with transcriptional regulation to explain clock- and system-driven mRNA abundances may reveal the coordination of DNA- and RNA-binding regulators that shape temporal transcriptomes in diverse mammalian tissues.

Materials and Methods {#s9}
=====================

For each section below, further details are included in [*SI Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental).

Data Processing for Total RNA-Seq in Mouse Liver Around the Clock. {#s10}
------------------------------------------------------------------

To quantify the temporal accumulation of pre-mRNA and mRNA in mouse liver, we used total RNA-seq data from ref. [@r8] (GEO accession no. GSE73554), in which livers of wild-type C57BL/6J male mice between 10 and 14 wk of age, under 12-h light/12-h dark and ad libitum feeding conditions, were collected every 2 h during 1 d (four biological replicates = 48 time points in total).

Modeling the Temporal Profiles of mRNA and Pre-mRNA. {#s11}
----------------------------------------------------

Here, we modeled the temporal accumulations of mRNA with the following differential equation:$${{dm\left( t \right)}/{dt}} = kp\left( t \right) - \gamma\left( t \right)m\left( t \right),$$

in which *m*(*t*) and *p*(*t*) denote the temporal accumulations (concentrations) of mRNA (*m*) and pre-mRNA (*p*), respectively. In M1 and M3, pre-mRNA accumulation is described by a constant *p*~0~. *γ*(*t*) describes temporal variation of mRNA degradation rate. In M1 and M2, *γ*(*t*) is set to a constant *γ*~0~. The parameter *k* represents the rate of pre-mRNA processing (defined here as the effective rate for processing of pre-mRNA into mRNA, combining intermediate steps such as splicing, pre-mRNA decay, and nuclear export) from pre-mRNA to mRNA, which is assumed to be fast on the scale of *γ*(*t*) and can thus be approximated as a gene-specific constant. For each gene, temporal profiles of mRNA and pre-mRNA were fitted with the four models (M1--M4) and the kinetic parameters, as well as their SEs and identifiabilities, were estimated.

Model Selection with the Bayesian Information Criterion. {#s12}
--------------------------------------------------------

To select the optimal model for each gene, given the measured read counts of mRNA and pre-mRNA, an approach combining the maximum likelihood ([@r55][@r56]--[@r57]) and the Bayesian information criterion (BIC) was used: BIC = −log(*L*) + *K* log(*N*), in which log(*L*) is the log-likelihood, *K* is the number of parameters, and *N* is the number of data points.

Validation of the Method with Simulations. {#s13}
------------------------------------------

To validate our model selection and parameter estimation, we tested the method with simulated data (200 synthetic genes) for models (M1--M4), taking kinetic parameters from realistic distributions.

Inference of mRBPs Involved in Rhythmic mRNA Degradation. {#s14}
---------------------------------------------------------

To infer mRBPs with rhythmic activities from the identified rhythmic mRNA degradations, we used genes from the two groups of [Fig. 6](#fig06){ref-type="fig"} and mRBP motif library in ref. [@r47]. 3′-UTR of mRNAs (RefSeq) for those genes were scanned with FIMO ([@r58]) to find hits to mRBP motifs, which are potentially responsible for rhythmic mRNA degradation. The rhythmic variation of mRNA degradation (in log scale) was assumed as a linear combination of diurnal activities of mRBP motifs \[analogous to linear models for transcription factor activities ([@r35], [@r48])\]. To control for overfitting and also redundancy of motifs, we employed regularized elastic-net linear regression \[implemented in R package glmnet ([@r59])\].

Rhythmicity Assessment Temporal RNA-Seq Datasets. {#s15}
-------------------------------------------------

Rhythmicity in mRNA abundances for transcripts classified in M3 ([Dataset S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1715225115/-/DCSupplemental)) in different conditions was assessed using a model selection approach as described in ref. [@r8].

GO Analysis. {#s16}
------------

GO analysis was performed using the TopGO R package ([@r60]).
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